Press release
TAVI Market Set to Revolutionize Cardiac Interventions, Poised to Exceed $16.32 billion by 2030
According to Next Move Strategy Consulting, the global TAVI market size is anticipated to surpass $16.32 billion by 2030 reflecting a CAGR of 14.6% during the forecast period till 2030. This surge is attributed to evolving consumer preferences, technological advancements, and an increasing emphasis on sustainability in household cleaning practices.Market Overview:
The TAVI market is witnessing a paradigm shift in cardiac interventions as innovative technologies and minimally invasive procedures gain prominence.
This surge is attributed to the increasing prevalence of valvular heart diseases, aging populations, and advancements in medical research and development. TAVI procedures offer a less invasive alternative to traditional open-heart surgeries, providing patients with faster recovery times and reduced hospital stays.
Request a FREE sample report, here, https://www.nextmsc.com/tavi-market/request-sample
Key Market Drivers:
1.Aging Population and Increased Life Expectancy: The global rise in life expectancy and an aging population contribute significantly to the prevalence of valvular heart diseases, driving the demand for TAVI procedures as a less invasive treatment option for elderly patients.
2.Technological Advancements: Ongoing advancements in medical technology, including improved valve designs, delivery systems, and imaging techniques, enhance the safety and efficacy of TAVI procedures, making them more accessible and reliable.
3.Increasing Incidence of Valvular Heart Diseases: The growing incidence of valvular heart diseases, such as aortic stenosis, has fueled the demand for effective and less invasive treatment options, positioning TAVI as a transformative solution.
4.Rising Patient Preference for Minimally Invasive Procedures: Patients increasingly prefer minimally invasive interventions due to quicker recovery times, reduced complications, and shorter hospital stays. TAVI, as a minimally invasive approach, aligns with this trend.
Market Segmentation:
The TAVI market includes various segments, including:
Procedure: Based on procedure, the market is categorised into Transfemoral Implantation, Transapical Implantation, and Transaortic Implantation.
End Users: Based on end users, the market is segmented into Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers.
Regional: Based on regional, the market is categorised into North America, Europe, Asia Pacific, and RoW.
For any queries, inquire before purchasing, here, https://www.nextmsc.com/tavi-market/inquire-before-buying
Outlook and Future Prospects:
Technological advancements, like the development of new-generation TAVI devices with lower infection risks, are poised to propel the market forward.
This is because these innovations will not only improve patient outcomes but also expand the pool of eligible candidates for the procedure. With fewer concerns about infection, patients who were previously deemed too high-risk for traditional TAVI might now be considered suitable, opening up a vast new market segment.
Access the full report, here, https://www.nextmsc.com/report/tavi-market
The TAVI market, despite its potential, faces some hurdles to growth. One major obstacle is the shortage of skilled healthcare professionals trained in this specific procedure. This lack of expertise limits the number of centers equipped to perform TAVI, restricting patient access. Additionally, the high cost of the TAVI procedure itself can act as a deterrent, particularly in regions with limited financial resources.
Avail customized reports: https://www.nextmsc.com/services
Regional Analysis:
North America held the lion's share of the global TAVI market and is expected to continue dominating the market during the forecast period. This is attributed to factors such as the presence of developed healthcare infrastructure along with high R&D expenditure for the development of these devices.
Also, the rise in the prevalence of coronary artery diseases, hypertension, or heart failure that needs surgical aortic treatment is supplementing the market growth. Moreover, the demand for TAVI is increasing due to the surging prevalence in the U.S., which consists of a large geriatric population, that is most vulnerable to valvular aortic stenosis.
On the contrary, Asia-Pacific is expected to exhibit a steady rise in the global TAVI market during the forecast period, due to factors such as increasing incidences of cardiovascular disorders, and rising accessibility to healthcare facilities in this region.
Also, growing medical tourism in countries such as Japan, Thailand, and Singapore, including procedures of TAVI in the region is expected to fuel the market in this region.
Competitive Landscape
The TAVI market comprises key players such as Abbott, JC Medical Inc., Meril Life Sciences Pvt. Ltd., HLT, Inc. (Bracco), Boston Scientific Corporation, JenaValve Technology Inc., Edwards Lifesciences Corporation, Medtronic, Venus Medtech (Hangzhou) Inc, and NVT AG(Blue Sail Medical) among others.
These players are actively indulging in R&D initiatives, product & technology innovations, and industrial collaborations to enhance their products and increase their sales growth and geographical reach.
Contact Us:
Next Move Strategy Consulting
Full Postal Address: 5th Floor, 867 BOYLSTON ST STE 500
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com
About Us:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider committed to delivering high-quality market research reports.
We assist multinational companies in gaining a competitive edge and expanding their industry presence by capturing a larger market share. Our research methodology combines primary research, secondary research, data mining, and data analytics to deliver reliable insights.
Over a decade, we have served over 1,000 global customers, including 90% of Fortune 500 companies. Our analysts constantly monitor high-growth markets and uncover hidden opportunities in various sectors. We offer top-quality syndicate and custom research reports across ten different industry verticals, catering to your unique business needs.
Our industry-standard delivery solutions, from pre-consultation to after-sales services, ensure an exceptional client experience and support informed strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release TAVI Market Set to Revolutionize Cardiac Interventions, Poised to Exceed $16.32 billion by 2030 here
News-ID: 3338811 • Views: …
More Releases from Next Move Strategy Consulting

Acne Medication Market Set for Exponential Growth with a Projected 3.2% CAGR by …
Introduction:
According to the Next Move Strategy Consulting, the Global Acne Medication Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 3.2% from 2024 to 2030.
The acne medication market is experiencing a transformative surge, driven by the increasing demand for effective solutions to address skincare concerns globally. As individuals prioritize skincare and beauty, the acne medication market emerges as a key player in providing innovative, targeted…

Unleashing the Potential of the Hemodialysis Market for Unprecedented Growth wit …
According to the Next Move Strategy Consulting, the Global Hemodialysis Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 3.60% from 2024 to 2030.
In recent years, the global healthcare landscape has witnessed a significant surge in demand for advanced renal care solutions, with the hemodialysis market emerging as a pivotal player in addressing the evolving needs of patients grappling with kidney-related issues.
Projections indicate that…

Managed Mobility Services Market Accelerates Towards USD 133.90 Billion Valuatio …
In a groundbreaking revelation, industry experts at Next Move Strategy Consulting unveil a compelling trajectory for the managed mobility services market, foreseeing an exceptional valuation of USD 133.90 billion by 2030. This robust ascent is underpinned by an extraordinary CAGR of 31.1%, signifying the pivotal role managed mobility services play in reshaping the digital landscape and empowering businesses with unparalleled mobility solutions.
Introduction:
Positioned as a linchpin in the broader landscape of…

The Infant Phototherapy Device Market Set for Remarkable Growth with a Projected …
Introduction:
According to the Next Move Strategy Consulting, the Global Infant Phototherapy Device Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 4.0% from 2024 to 2030.
The global infant phototherapy device market is poised for unprecedented growth, driven by the increasing demand for advanced neonatal care solutions and a growing focus on improving infant health outcomes. This comprehensive analysis delves into the key drivers, market segmentation,…
More Releases for TAVI
Global Transcatheter Aortic Valve Implantation (TAVI) Market Set to Experience R …
July 19, 2024 The global Transcatheter Aortic Valve Implantation (TAVI) market is projected to witness significant growth over the forecast period of 2024 to 2031, driven by increasing demand for minimally invasive surgical procedures and advancements in medical technology. This press release provides an in-depth market analysis, highlighting key players, recent developments, and market trends.
Market Overview
Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure for treating severe aortic…
Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market Size, Sha …
The global transcatheter aortic valve replacement (TAVR) market was valued at $3.12Billion and global transcatheter aortic valve implantation (TAVI) procedures market was valued at $7.64 Billion in 2017 and the combined market is forecast to grow at a modest25.3 % CAGR between 2018 and 2025, culminating in 2025 global sales of $XX.64 Billion.
Transcatheter aortic valve replacement (TAVR) is a type of surgery in which a new valve replaced without…
Transcatheter Heart Valve Replacement (TAVI) Market: Drivers, Restraint & Future …
A heart valve is present in arteries and veins and facilitates blood flow only in one direction through the heart. The four major valves in the heart are two atrioventricular valves known as bicuspid valve and tricuspid valve and two semilunar valves known as aortic valve and pulmonary valve. A heart valve separates the atria, ventricles and blood vessels from each other. A heart valve is pushed open to allow…
Transcatheter Heart Valve Replacement (TAVI) Market to Significant Growth Forese …
A heart valve is present in arteries and veins and facilitates blood flow only in one direction through the heart. The four major valves in the heart are two atrioventricular valves known as bicuspid valve and tricuspid valve and two semilunar valves known as aortic valve and pulmonary valve. A heart valve separates the atria, ventricles and blood vessels from each other. A heart valve is pushed open to allow…
FMI Releases New Report on the Transcatheter Heart Valve Replacement (TAVI) Mark …
A heart valve is present in arteries and veins and facilitates blood flow only in one direction through the heart. The four major valves in the heart are two atrioventricular valves known as bicuspid valve and tricuspid valve and two semilunar valves known as aortic valve and pulmonary valve. A heart valve separates the atria, ventricles and blood vessels from each other. A heart valve is pushed open to allow…
Transcatheter Heart Valve Replacement (TAVI) Market Globally Expected to Drive G …
A heart valve is present in arteries and veins and facilitates blood flow only in one direction through the heart. The four major valves in the heart are two atrioventricular valves known as bicuspid valve and tricuspid valve and two semilunar valves known as aortic valve and pulmonary valve. A heart valve separates the atria, ventricles and blood vessels from each other. A heart valve is pushed open to allow…